These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9455499)

  • 41. A novel strategy for the detection and definition of HLA-specific antibodies in patients awaiting renal transplantation.
    Worthington JE; Langton A; Liggett H; Robson AJ; Martin S
    Transpl Int; 1998; 11 Suppl 1():S372-6. PubMed ID: 9665019
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Detection and specification of noncomplement binding anti-HLA alloantibodies.
    Arnold ML; Zacher T; Dechant M; Kalden JR; Doxiadis II; Spriewald BM
    Hum Immunol; 2004 Nov; 65(11):1288-96. PubMed ID: 15556679
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A human monoclonal antibody against HLA-Cw1 and a human monoclonal antibody against an HLA-A locus determinant derived from a single uniparous female.
    Mulder A; Kardol MJ; Uit het Broek CM; Tanke-Visser J; Young NT; Claas FH
    Tissue Antigens; 1998 Oct; 52(4):393-6. PubMed ID: 9820605
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative reactivity of different HLA-G monoclonal antibodies to soluble HLA-G molecules.
    Fournel S; Huc X; Aguerre-Girr M; Solier C; Legros M; Praud-Brethenou C; Moussa M; Chaouat G; Berrebi A; Bensussan A; Lenfant F; Le Bouteiller P
    Tissue Antigens; 2000 Jun; 55(6):510-8. PubMed ID: 10902607
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Experience on identification of cross-reactive group specificity performed by anti-human globulin panel reactive antibody tests].
    Sohn YH; Cha CH; Kim MH; Ko SY; Oh HB
    Korean J Lab Med; 2008 Oct; 28(5):362-70. PubMed ID: 18971617
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Early renal graft function deterioration in recipients with preformed anti-MICA antibodies: partial contribution of complement-dependent cytotoxicity.
    Sánchez-Zapardiel E; Castro-Panete MJ; Mancebo E; Morales P; Laguna-Goya R; Morales JM; Apaza J; de Andrés A; Talayero P; Paz-Artal E
    Nephrol Dial Transplant; 2016 Jan; 31(1):150-60. PubMed ID: 26323481
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Luminex technology for anti-HLA antibody screening: evaluation of performance and of impact on laboratory routine.
    Colombo MB; Haworth SE; Poli F; Nocco A; Puglisi G; Innocente A; Serafini M; Messa P; Scalamogna M
    Cytometry B Clin Cytom; 2007 Nov; 72(6):465-71. PubMed ID: 17397064
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The single antigen expressing lines (SALs) concept: an excellent tool for screening for HLA-specific antibodies.
    Zoet YM; Eijsink C; Kardol MJ; Franke-van Dijk ME; Wilson GL; de Paus R; Mickelson E; Heemskerk M; van den Elsen PJ; Claas FH; Mulder A; Doxiadis II
    Hum Immunol; 2005 May; 66(5):519-25. PubMed ID: 15935889
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunogenicity of the soluble isoforms of HLA-G.
    Hunt JS; Pace JL; Morales PJ; Ober C
    Mol Hum Reprod; 2003 Nov; 9(11):729-35. PubMed ID: 14561816
    [TBL] [Abstract][Full Text] [Related]  

  • 50. HLAMatchmaker-based analysis of human monoclonal antibody reactivity demonstrates the importance of an additional contact site for specific recognition of triplet-defined epitopes.
    Duquesnoy RJ; Mulder A; Askar M; Fernandez-Vina M; Claas FH
    Hum Immunol; 2005 Jul; 66(7):749-61. PubMed ID: 16112022
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of the established standard complement-dependent cytotoxicity and flow cytometric crossmatch assays with a novel ELISA-based HLA crossmatch procedure.
    Altermann WW; Seliger B; Sel S; Wendt D; Schlaf G
    Histol Histopathol; 2006 Oct; 21(10):1115-24. PubMed ID: 16835834
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Detection of HLA class I-specific antibodies by the QuikScreen enzyme-linked immunosorbent assay.
    Lucas DP; Paparounis ML; Myers L; Hart JM; Zachary AA
    Clin Diagn Lab Immunol; 1997 May; 4(3):252-7. PubMed ID: 9144358
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Determination of acceptable HLA mismatches in highly sensitized patients by soluble HLA class I ELISA inhibition.
    Koelman CA; van Beelen E; Witvliet MD; Doxiadis II; Claas FH
    Transplantation; 2000 Feb; 69(4):656-60. PubMed ID: 10708125
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of ELISA QuikScreen and PRA-STAT with CDC-AHG for PRA determination.
    Bishara A; Sherman L; Freidlander M; Eid A; Brautbar C
    Transplant Proc; 1999 Jun; 31(4):1878. PubMed ID: 10371980
    [No Abstract]   [Full Text] [Related]  

  • 55. Anti-HLA-A, -B, -DR, -DQB1 and -DQA1 antibodies reactive epitope determination with HLAMatchmaker in multipare awaiting list for heart transplant.
    Resse M; Paolillo R; Casamassimi A; Cavalca F; Fiorito C; Maiello C; Napoli C
    Hum Immunol; 2013 Aug; 74(8):937-41. PubMed ID: 23628396
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Flow cytometric evaluation of pregnancy-induced anti-HLA immunization and blood transfusion-induced reactivation.
    Rebibou JM; Chabod J; Alcalay D; Coussediere MC; Deteix P; Touchard G; Dupont I; Thévenin C; Chalopin JM; Tiberghien P
    Transplantation; 2002 Aug; 74(4):537-40. PubMed ID: 12352915
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Analysis of HLA specificity of human monoclonal antibodies by cytofluorimetry and cell ELISA.
    Pistillo MP; Tazzari PL; Mazzoleni O; Urlacher A; Falco M; Vitale M; Karr RW; Ferrara GB
    Eur J Immunogenet; 1991; 18(5-6):345-53. PubMed ID: 1772879
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of using different laboratory assays to detect human leukocyte antigen antibodies in female blood donors.
    Lopes LB; Fabron A; Chiba AK; Ruiz MO; Bordin JO
    Transfusion; 2010 Apr; 50(4):902-8. PubMed ID: 20003053
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevalence and specificity of immunoglobulin G and immunoglobulin A non-complement-binding anti-HLA alloantibodies in retransplant candidates.
    Arnold ML; Dechant M; Doxiadis II; Spriewald BM
    Tissue Antigens; 2008 Jul; 72(1):60-6. PubMed ID: 18588575
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Detection of HLA-specific IGG antibodies using single recombinant HLA alleles: the MonoLISA assay.
    Barnardo MC; Harmer AW; Shaw OJ; Ogg GS; Bunce M; Vaughan RW; Morris PJ; Welsh KI
    Transplantation; 2000 Aug; 70(3):531-6. PubMed ID: 10949199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.